Alison Smigova

561 total citations
7 papers, 293 citations indexed

About

Alison Smigova is a scholar working on Molecular Biology, Neurology and Biotechnology. According to data from OpenAlex, Alison Smigova has authored 7 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Neurology and 2 papers in Biotechnology. Recurrent topics in Alison Smigova's work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Cancer Research and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Alison Smigova is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Cancer Research and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Alison Smigova collaborates with scholars based in United Kingdom, Australia and France. Alison Smigova's co-authors include Hervé Boutin, Renaud Maroy, Christopher Cawthorne, Alexander Gerhard, Paul A. Jones, Jesús M. Pradillo, Katie N. Murray, William Trigg, C. Prenant and Karl Herholz and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and British Journal of Cancer.

In The Last Decade

Alison Smigova

7 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Smigova United Kingdom 7 114 103 63 45 43 7 293
Kristen R. Hollinger United States 13 180 1.6× 66 0.6× 37 0.6× 26 0.6× 56 1.3× 17 342
Isabelle Paré Canada 9 91 0.8× 107 1.0× 113 1.8× 54 1.2× 40 0.9× 18 364
Amanda A. Riley United States 8 69 0.6× 50 0.5× 26 0.4× 32 0.7× 31 0.7× 15 286
Y. Venel France 6 94 0.8× 114 1.1× 72 1.1× 92 2.0× 38 0.9× 16 363
Cristina Barca Germany 11 65 0.6× 101 1.0× 31 0.5× 60 1.3× 21 0.5× 15 303
Sanjay Munireddy United States 7 76 0.7× 136 1.3× 214 3.4× 71 1.6× 45 1.0× 9 411
Benoît Hosten France 10 79 0.7× 61 0.6× 35 0.6× 50 1.1× 27 0.6× 25 267
Anhui Yao China 9 78 0.7× 72 0.7× 31 0.5× 22 0.5× 40 0.9× 20 308
Chen Luo China 11 144 1.3× 77 0.7× 24 0.4× 34 0.8× 23 0.5× 21 404
Julie Czerkowicz United States 7 59 0.5× 63 0.6× 135 2.1× 39 0.9× 41 1.0× 14 337

Countries citing papers authored by Alison Smigova

Since Specialization
Citations

This map shows the geographic impact of Alison Smigova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Smigova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Smigova more than expected).

Fields of papers citing papers by Alison Smigova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Smigova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Smigova. The network helps show where Alison Smigova may publish in the future.

Co-authorship network of co-authors of Alison Smigova

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Smigova. A scholar is included among the top collaborators of Alison Smigova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Smigova. Alison Smigova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Chaney, Aisling M., Martin Bauer, Alison Smigova, et al.. (2017). Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe×PS1Δe9 transgenic mouse model of Alzheimer's disease. Journal of Neurochemistry. 144(3). 318–335. 28 indexed citations
2.
Boutin, Hervé, Katie N. Murray, Jesús M. Pradillo, et al.. (2014). 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. European Journal of Nuclear Medicine and Molecular Imaging. 42(3). 503–511. 100 indexed citations
3.
Cawthorne, Christopher, Natalie Burrows, Roben G. Gieling, et al.. (2013). [18F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941. Molecular Cancer Therapeutics. 12(5). 819–828. 12 indexed citations
4.
Boutin, Hervé, C. Prenant, Renaud Maroy, et al.. (2013). [18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats. PLoS ONE. 8(2). e56441–e56441. 78 indexed citations
5.
Kadirvel, Manikandan, Christopher Cawthorne, Emily J. Rowling, et al.. (2013). Detection of apoptosis by PET/CT with the diethyl ester of [18F]ML-10 and fluorescence imaging with a dansyl analogue. Bioorganic & Medicinal Chemistry. 22(1). 341–349. 14 indexed citations
6.
Cawthorne, Christopher, C. Prenant, Alison Smigova, et al.. (2010). Biodistribution, pharmacokinetics and metabolism of interleukin‐1 receptor antagonist (IL‐1RA) using [18F]‐IL1RA and PET imaging in rats. British Journal of Pharmacology. 162(3). 659–672. 42 indexed citations
7.
Lunt, Sarah Jane, Christopher Cawthorne, M. A. Ali, et al.. (2010). The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy. British Journal of Cancer. 103(2). 201–208. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026